SAQUINAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where SAQUINAVIR was used for Maternal exposure timing unspecified.
Most Reported Side Effects for SAQUINAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Lipodystrophy acquired | 186 | 23.5% | 0 | 0 |
| Eyelid ptosis | 169 | 21.3% | 0 | 0 |
| Mitochondrial toxicity | 165 | 20.8% | 0 | 1 |
| Diplopia | 161 | 20.3% | 0 | 0 |
| Foetal exposure during pregnancy | 105 | 13.3% | 9 | 27 |
| Dysphagia | 103 | 13.0% | 5 | 5 |
| Viral mutation identified | 82 | 10.4% | 0 | 2 |
| Drug resistance | 77 | 9.7% | 5 | 10 |
| Progressive external ophthalmoplegia | 74 | 9.3% | 0 | 0 |
| Pathogen resistance | 67 | 8.5% | 0 | 2 |
| Ophthalmoplegia | 66 | 8.3% | 0 | 0 |
| Virologic failure | 66 | 8.3% | 0 | 15 |
| Blood lactic acid increased | 60 | 7.6% | 1 | 10 |
| Treatment failure | 51 | 6.4% | 1 | 0 |
| Anaemia | 41 | 5.2% | 2 | 25 |
Other Indications for SAQUINAVIR
Hiv infection (526)
Product used for unknown indication (110)
Antiretroviral therapy (62)
Acquired immunodeficiency syndrome (14)
Hiv-2 infection (10)
Hepatitis c (8)
Antiviral treatment (7)
Chronic hepatitis c (7)
Hiv test positive (7)
Hiv infection cdc category c (6)
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)